
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15990455
[patent_doc_number] => 20200171098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/572419
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572419 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Sep 15, 2019 | Abandoned |
Array
(
[id] => 16841734
[patent_doc_number] => 11013793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Multivalent pneumococcal vaccines
[patent_app_type] => utility
[patent_app_number] => 16/569579
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 26
[patent_no_of_words] => 110525
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569579 | Multivalent pneumococcal vaccines | Sep 11, 2019 | Issued |
Array
(
[id] => 16125983
[patent_doc_number] => 10696733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Microbe-binding molecules and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/553635
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 53680
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553635 | Microbe-binding molecules and uses thereof | Aug 27, 2019 | Issued |
Array
(
[id] => 17035166
[patent_doc_number] => 20210252124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMBINATION VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/270594
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270594 | Combination vaccine | Aug 25, 2019 | Issued |
Array
(
[id] => 15586417
[patent_doc_number] => 20200069743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => METHOD OF AMELIORATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING PARABACTEROIDES GOLDSTEINII
[patent_app_type] => utility
[patent_app_number] => 16/541308
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16541308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/541308 | Method of ameliorating chronic obstructive pulmonary disease using | Aug 14, 2019 | Issued |
Array
(
[id] => 15435495
[patent_doc_number] => 20200031931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => ANTI PD-1 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/538448
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538448 | Anti PD-1 antibodies | Aug 11, 2019 | Issued |
Array
(
[id] => 15435503
[patent_doc_number] => 20200031935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => ANTI PD-L1 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/538440
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538440 | Anti PD-L1 antibodies | Aug 11, 2019 | Issued |
Array
(
[id] => 15451339
[patent_doc_number] => 20200038493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/537022
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/537022 | Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy | Aug 8, 2019 | Issued |
Array
(
[id] => 17168861
[patent_doc_number] => 20210322531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => MUCOSAL VACCINE COMPOSITION FOR BOVINE MASTITIS
[patent_app_type] => utility
[patent_app_number] => 17/265020
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265020 | MUCOSAL VACCINE COMPOSITION FOR BOVINE MASTITIS | Aug 1, 2019 | Abandoned |
Array
(
[id] => 15267515
[patent_doc_number] => 20190382491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANTI-CD137
[patent_app_type] => utility
[patent_app_number] => 16/529230
[patent_app_country] => US
[patent_app_date] => 2019-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16529230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/529230 | TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANTI-CD137 | Jul 31, 2019 | Abandoned |
Array
(
[id] => 15993431
[patent_doc_number] => 20200172586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => NOVEL PROTEINS AND DETECTION METHODS
[patent_app_type] => utility
[patent_app_number] => 16/526688
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526688 | NOVEL PROTEINS AND DETECTION METHODS | Jul 29, 2019 | Abandoned |
Array
(
[id] => 16640911
[patent_doc_number] => 10918732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Glycoconjugates and methods for their use
[patent_app_type] => utility
[patent_app_number] => 16/523688
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13278
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523688 | Glycoconjugates and methods for their use | Jul 25, 2019 | Issued |
| 16/519161 | COMPOSITIONS AND METHODS FOR TREATING THE EYE | Jul 22, 2019 | Abandoned |
Array
(
[id] => 15408021
[patent_doc_number] => 20200024332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 16/518565
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/518565 | Antibody | Jul 21, 2019 | Issued |
Array
(
[id] => 19922987
[patent_doc_number] => 12297258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Antibodies against
[patent_app_type] => utility
[patent_app_number] => 17/260966
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 46
[patent_no_of_words] => 16362
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260966 | Antibodies against | Jul 15, 2019 | Issued |
Array
(
[id] => 17065822
[patent_doc_number] => 20210268037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ANAEROSTIPES HADRUS FOR USE IN PROMOTING HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/255126
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255126 | ANAEROSTIPES HADRUS FOR USE IN PROMOTING HEALTH | Jun 24, 2019 | Abandoned |
Array
(
[id] => 14961381
[patent_doc_number] => 20190308168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => CHROMATOGRAPHY LIGAND COMPRISING DOMAIN C FROM STAPHYLOCOCCUS AUREUS PROTEIN A FOR ANTIBODY ISOLATION
[patent_app_type] => utility
[patent_app_number] => 16/443600
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/443600 | Chromatography ligand comprising domain C from | Jun 16, 2019 | Issued |
Array
(
[id] => 19043586
[patent_doc_number] => 11932670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Glycosylated ComP pilin variants, methods of making and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/251994
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 38
[patent_no_of_words] => 25355
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251994 | Glycosylated ComP pilin variants, methods of making and uses thereof | Jun 13, 2019 | Issued |
Array
(
[id] => 19650061
[patent_doc_number] => 12171821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/251121
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17931
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251121 | None | Jun 12, 2019 | Issued |
Array
(
[id] => 17814312
[patent_doc_number] => 11419900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Methods and compositions for the treatment of C. difficile
[patent_app_type] => utility
[patent_app_number] => 15/734747
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 33
[patent_no_of_words] => 14629
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734747
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734747 | Methods and compositions for the treatment of C. difficile | Jun 5, 2019 | Issued |